Cargando…
Immunomodulatory Molecules On Lung Cancer Stem Cells From Lymph Nodes Aspirates
Over the past decade, immune checkpoint inhibitors have revolutionized the treatment of non-small cell lung cancer (NSCLC). Unfortunately, not all patients benefit from PD-(L)1 blockade, yet, the PD-L1 tumor cell expression is the only approved biomarker, and other biomarkers have been investigated....
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226167/ https://www.ncbi.nlm.nih.gov/pubmed/32244422 http://dx.doi.org/10.3390/cancers12040838 |